Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rettig

Showing results (31-40 of 144) with videos related to

Pageof 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
Drug interactions between the proteasome inhibitor bortezomib and cytotoxic chemotherapy, tumor necrosis factor (TNF) alpha, and TNF-related apoptosis-inducing ligand in prostate cancerJiabin An, Yi-Ping Sun, Julian Adams, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2018
Functional profiling of circulating tumor cells with an integrated vortex capture and single-cell protease activity assayManjima Dhar, Jeffrey Nam Lam, Tonya Walser, et al.
Current Geriatrics Reports|November 7, 2015
The Crossroads of Geriatric Cardiology and Cardio-OncologyKim-Lien Nguyen, Rami Alrezk, Pejman G Mansourian, et al.
Urology|August 11, 2004
Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapyFrancisco A Conde, Linda Sarna, Roberta K Oka, et al.
Cancer Cell|November 4, 2008
Inactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-kappaB activationJiabin An, Deqiong Mo, Huiren Liu, et al.
Oncotarget|March 24, 2015
YB-1 and MTA1 protein levels and not DNA or mRNA alterations predict for prostate cancer recurrenceChristine Moore Sheridan, Tristan R Grogan, Hao G Nguyen, et al.
Cancer Epidemiology|December 27, 2017
Temporal and geospatial trends of pediatric cancer incidence in Nebraska over a 24-year periodP A Farazi, S Watanabe-Galloway, L Westman, et al.
Biomolecules|February 26, 2025
Correction: Hao et al. Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin with Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Homolog Knockout Mice. <i>Biomolecules</i> 2024, <i>14</i>, 105Qiongyu Hao, Susanne M Henning, Clara E Magyar, et al.
Biomolecules|January 23, 2024
Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin with Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Homolog Knockout MiceQiongyu Hao, Susanne M Henning, Clara E Magyar, et al.
Cancer Research|February 9, 2013
Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinomaJiabin An, Huiren Liu, Clara E Magyar, et al.
Pageof 15

Showing results (31-40 of 144) with videos related to

Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2003
Drug interactions between the proteasome inhibitor bortezomib and cytotoxic chemotherapy, tumor necrosis factor (TNF) alpha, and TNF-related apoptosis-inducing ligand in prostate cancerJiabin An, Yi-Ping Sun, Julian Adams, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2018
Functional profiling of circulating tumor cells with an integrated vortex capture and single-cell protease activity assayManjima Dhar, Jeffrey Nam Lam, Tonya Walser, et al.
Current Geriatrics Reports|November 7, 2015
The Crossroads of Geriatric Cardiology and Cardio-OncologyKim-Lien Nguyen, Rami Alrezk, Pejman G Mansourian, et al.
Urology|August 11, 2004
Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapyFrancisco A Conde, Linda Sarna, Roberta K Oka, et al.
Cancer Cell|November 4, 2008
Inactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-kappaB activationJiabin An, Deqiong Mo, Huiren Liu, et al.
Oncotarget|March 24, 2015
YB-1 and MTA1 protein levels and not DNA or mRNA alterations predict for prostate cancer recurrenceChristine Moore Sheridan, Tristan R Grogan, Hao G Nguyen, et al.
Cancer Epidemiology|December 27, 2017
Temporal and geospatial trends of pediatric cancer incidence in Nebraska over a 24-year periodP A Farazi, S Watanabe-Galloway, L Westman, et al.
Biomolecules|February 26, 2025
Correction: Hao et al. Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin with Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Homolog Knockout Mice. <i>Biomolecules</i> 2024, <i>14</i>, 105Qiongyu Hao, Susanne M Henning, Clara E Magyar, et al.
Biomolecules|January 23, 2024
Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin with Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Homolog Knockout MiceQiongyu Hao, Susanne M Henning, Clara E Magyar, et al.
Cancer Research|February 9, 2013
Hyperactivated JNK is a therapeutic target in pVHL-deficient renal cell carcinomaJiabin An, Huiren Liu, Clara E Magyar, et al.
Pageof 15